Active, not recruitingPHASE2, PHASE3NCT02016924
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
Studying Acquired immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gilead Sciences
- Principal Investigator
- Gilead Study DirectorGilead Sciences
- Intervention
- ATV(drug)
- Enrollment
- 133 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2014 – 2027
Study locations (23)
- Pediatric Infectious Disease Associates, Long Beach, California, United States
- Peter Morton Medical Building, Los Angeles, California, United States
- University of Colorado Denver, Aurora, Colorado, United States
- The George Washington University, Washington D.C., District of Columbia, United States
- University of South Florida, Tampa, Florida, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- University of Texas Health Science Center of Houston, Houston, Texas, United States
- Hospital General de Agudos Cosme Argerich, Buenos Aires, Argentina
- Helios Salud, Buenos Aires, Argentina
- University of the Free State, Bloemfontein, South Africa
- University of Stellenbosch, Cape Town, South Africa
- King Edward VIII Hospital, Durban, South Africa
- Rahima Clinical Trials, a Division of Wits Health Consortium (Pty) Ltd, Johannesburg, South Africa
- The Aurum Institute: Pretoria Clinical Research Centre, Pretoria, South Africa
- Perinatal HIV Research Unit, Soweto, South Africa
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02016924 on ClinicalTrials.govOther trials for Acquired immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07298785Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyUniversity of California, San Francisco
- ENROLLING BY INVITATIONNANCT07192419Promoting Aging and Thriving With HIVIndiana University
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07182838Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic MixHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- RECRUITINGNANCT07064785Video-Intervention to Inspire Treatment Adherence for Life for AdolescentsBaylor College of Medicine
- RECRUITINGNANCT06999928Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVIndiana University
- ACTIVE NOT RECRUITINGNANCT07074899Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in PeruFred Hutchinson Cancer Center
- RECRUITINGNANCT06389565Change My Story Task Shifted Mental Health InterventionMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNANCT06913660ALHIV Smartphone Game StudyEmory University